Bardy G, Virsolvy A, Quignard JF, Ravier MA, Bertrand G, Dalle S, et al
The rationale for blending these two peptides stems from their non-overlapping receptor targets and complementary metabolic effects: Amylin Pathway (Cagrilintide): Targets amylin receptors in the brainstem Creates meal-specific satiety signals Slows gastric emptying through distinct mechanisms Reduces meal size and eating frequency Triple Agonist Pathway (Retatrutide): Activates GIP, GLP-1, and glucagon receptors Enhances insulin secretion and glucose metabolism Increases energy expenditure through glucagon effects Provides broader metabolic regulation When combined, these pathways could theoretically provide additive or synergistic effects on weight management and metabolic function
Sign-up today
CRC is the third cause of cancer death worldwide
This is the sharpest single difference in the comparison, and it colors every downstream statement about dosing and safety
flavouring, antioxidant: E307 alphatocopherol)